-
Pharmaceutical giant Gilead Sciences Inc. on Wednesday announced that an early trial of its experimental anti-viral drug remdesivir indicates that the medication could be effective in treating coronavirus patients early in the infection’s onset. According to the study, 62 percent of coronavirus patients treated with the drug early on were discharged from the hospital, while …
-
The new coronavirus made Dr. Jag Singh a patient at his own hospital. His alarm grew as he saw an X-ray of his pneumonia-choked lungs and colleagues asked his wishes about life support while wheeling him into Massachusetts General’s intensive care unit. When they offered him a chance to help test remdesivir, an experimental drug …
-
Johnson & Johnson said on Monday that it and the US government will invest $1 billion to create enough manufacturing capacity to make more than 1 billion doses of a vaccine it is testing to stop the new coronavirus that has killed more than 35,000 people around the world. As part of the arrangement, the …
Pharmaceutical giant Gilead Sciences Inc. on Wednesday announced that an early trial of its experimental anti-viral drug remdesivir indicates that the medication could be effective in treating coronavirus patients early in the infection’s onset. According to the study, 62 percent of coronavirus patients treated with the drug early on were discharged from the hospital, while …
